Retension Pharmaceuticals Inc. (RTSN)
$11.63+2.74%Close
FLAT
Key stats
- Market cap
- $44M
- Beta
- 0.00
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE20.34
INDUSTRY PE104.65
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA0.00
Company news
FAQ
- What is LOPJLB’s current signal on RTSN?
- LOPJLB’s latest quantitative signal on Retension Pharmaceuticals Inc. (RTSN) is FLAT. Signals are updated daily.
- What market regime is RTSN in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does Retension Pharmaceuticals Inc. (RTSN) do?
- Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the develo…